BRPI0919412A8 - composição imunonutricional e nutricional,agente intensificador de resposta imunológica e uso do mesmo. - Google Patents
composição imunonutricional e nutricional,agente intensificador de resposta imunológica e uso do mesmo.Info
- Publication number
- BRPI0919412A8 BRPI0919412A8 BRPI0919412A BRPI0919412A BRPI0919412A8 BR PI0919412 A8 BRPI0919412 A8 BR PI0919412A8 BR PI0919412 A BRPI0919412 A BR PI0919412A BR PI0919412 A BRPI0919412 A BR PI0919412A BR PI0919412 A8 BRPI0919412 A8 BR PI0919412A8
- Authority
- BR
- Brazil
- Prior art keywords
- immunonutritional
- immune response
- nutritional composition
- enhancing agent
- response enhancing
- Prior art date
Links
- 230000002708 enhancing effect Effects 0.000 title 1
- 230000028993 immune response Effects 0.000 title 1
- 235000016709 nutrition Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1783—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9825808P | 2008-09-19 | 2008-09-19 | |
US24107409P | 2009-09-10 | 2009-09-10 | |
PCT/US2009/056599 WO2010033426A2 (en) | 2008-09-19 | 2009-09-11 | Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0919412A2 BRPI0919412A2 (pt) | 2015-12-15 |
BRPI0919412A8 true BRPI0919412A8 (pt) | 2018-03-13 |
Family
ID=41786110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0919412A BRPI0919412A8 (pt) | 2008-09-19 | 2009-09-11 | composição imunonutricional e nutricional,agente intensificador de resposta imunológica e uso do mesmo. |
Country Status (12)
Country | Link |
---|---|
US (1) | US9827216B2 (pt) |
EP (2) | EP2687209A1 (pt) |
JP (3) | JP2012502998A (pt) |
CN (1) | CN102215837B (pt) |
AU (1) | AU2009293476B2 (pt) |
BR (1) | BRPI0919412A8 (pt) |
CA (1) | CA2736774C (pt) |
MX (1) | MX2011002984A (pt) |
MY (1) | MY155635A (pt) |
RU (1) | RU2011115182A (pt) |
WO (1) | WO2010033426A2 (pt) |
ZA (1) | ZA201102909B (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150104425A1 (en) * | 2006-07-24 | 2015-04-16 | CortControl, Inc. | Medical food for high cortisol breast cancer |
EP2687209A1 (en) | 2008-09-19 | 2014-01-22 | Nestec S.A. | Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
BR112012007418A2 (pt) * | 2009-09-25 | 2015-08-25 | Nestec Sa | Composições nutricionais incluindo teanina e nucleotídeos exógenos. |
SG193246A1 (en) * | 2011-03-31 | 2013-10-30 | Nestec Sa | Nutritional compositions for increasing arginine levels and methods of using same |
WO2012141575A1 (en) * | 2011-04-14 | 2012-10-18 | N.V.Nutricia | Combination of epa, dpa and/or dha with a chemotherapeutic agent |
EP2876167A1 (en) | 2013-11-21 | 2015-05-27 | Institut Gustave Roussy | Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment |
US20150366941A1 (en) * | 2014-06-19 | 2015-12-24 | Cortcontrol | Human disease treatment with medical food formulation |
CN107810264B (zh) * | 2015-06-30 | 2022-08-05 | 雀巢产品有限公司 | 适于保护微生物的组合物 |
EP3352586A4 (en) * | 2015-09-21 | 2019-05-15 | The Board Of Trustees Of The Leland Stanford Junior University | NUTRITIONAL ANTICANCER TREATMENT |
CN105943564A (zh) * | 2016-04-21 | 2016-09-21 | 徐忠琴 | 用于胰腺癌放化疗后减轻副作用的药物组合物 |
CN106722972A (zh) * | 2017-03-21 | 2017-05-31 | 上海中优医学检验所有限公司 | 针对免疫调控能力相关基因个体化配方食品及其制备方法 |
US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
WO2019118519A1 (en) | 2017-12-11 | 2019-06-20 | Filtricine, Inc. | Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy |
CN111714616A (zh) * | 2019-07-17 | 2020-09-29 | 江苏西宏生物医药有限公司 | 一种用于抗肿瘤的组合物 |
JP6838752B2 (ja) * | 2019-08-30 | 2021-03-03 | 株式会社東洋新薬 | 血流改善組成物 |
CN110754656A (zh) * | 2019-11-07 | 2020-02-07 | 上海奥医高科技实业有限公司 | 一种淋巴肿瘤功能专用型临床营养配方及其制备方法 |
CN111840523B (zh) * | 2020-08-24 | 2021-08-31 | 中国农业科学院北京畜牧兽医研究所 | 一种含活性蛋白和活性脂肪酸的抗癌症的药物组合物 |
CN114344342B (zh) * | 2021-12-29 | 2023-06-30 | 广东南芯医疗科技有限公司 | 副干酪乳杆菌Lp. R3在制备预防或治疗肿瘤药物中的应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5576351A (en) | 1989-12-29 | 1996-11-19 | Mcgaw, Inc. | Use of arginine as an immunostimulator |
AUPN271295A0 (en) | 1995-05-02 | 1995-05-25 | Gropep Pty Ltd | Method of treatment |
US5330972A (en) | 1993-05-28 | 1994-07-19 | Abbott Laboratories | Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus |
US5438042B1 (en) * | 1993-10-08 | 1997-08-26 | Sandoz Nutrition Ltd | Enteral nutritional composition having amino acid profile |
EP0818529B1 (fr) | 1996-07-09 | 2005-06-22 | Societe Des Produits Nestle S.A. | Procédé de séchage par pulvérisation |
US6210700B1 (en) | 1997-01-14 | 2001-04-03 | Novartis Nutrition Ag | Enhancement of transplant graft survival through nutritional immunomodulation with omega-9 fatty acid dietary supplement therapy |
FR2802212B1 (fr) | 1999-12-13 | 2002-03-01 | Agronomique Inst Nat Rech | Procede pour l'obtention d'une poudre contenant des micro-organismes viables, poudre obtenue selon ce procede et dispositif pour sa mise en oeuvre |
ATE427037T1 (de) | 2001-02-19 | 2009-04-15 | Nestle Sa | Essbares produkt enthaltend probiotische kulturen |
US20030068385A1 (en) | 2001-03-23 | 2003-04-10 | Moyer Mary Pat | Accelerated action fatty acid (AAFA) promotes health of normal tissues and minimizes the toxic side effects of chemotherapy |
EP1434602B1 (en) | 2001-10-06 | 2014-12-17 | Merial Limited | CpG plus oil in water emulsion as adjuvant system for truncated bovine herpesvirus-1 glycoprotein D |
EP1572093B1 (en) | 2002-08-01 | 2013-04-17 | Eisai Inc. | Prevention of cancer with glutamine |
CN1889856B (zh) | 2003-10-16 | 2011-03-02 | 雀巢技术公司 | 对抗化疗法和放射疗法的副作用的营养组合物 |
US20080090848A1 (en) * | 2004-09-03 | 2008-04-17 | Christopher Penney | Substituted Purinyl Derivatives With Immunomodulator And Chemoprotective Activity And Use Alone Or With Medium-Chain Length Fatty Acids Or Glycerides |
DE102005052367A1 (de) | 2005-10-31 | 2007-05-03 | Robert Bosch Gmbh | Messgerät und Verfahren zur Ortung von in einem Medium eingeschlossenen Objekten mittels elektromagnetischer HF-Signale |
CA2778823A1 (en) | 2006-04-04 | 2007-10-11 | Nestec S.A. | Treatments using citrulline |
JPWO2008047853A1 (ja) * | 2006-10-19 | 2010-02-25 | 味の素株式会社 | 胃食道逆流症の予防・治療剤 |
EP2687209A1 (en) | 2008-09-19 | 2014-01-22 | Nestec S.A. | Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
-
2009
- 2009-09-11 EP EP13189251.5A patent/EP2687209A1/en not_active Withdrawn
- 2009-09-11 MX MX2011002984A patent/MX2011002984A/es not_active Application Discontinuation
- 2009-09-11 US US13/063,589 patent/US9827216B2/en active Active
- 2009-09-11 EP EP09792442A patent/EP2344150A2/en not_active Withdrawn
- 2009-09-11 AU AU2009293476A patent/AU2009293476B2/en active Active
- 2009-09-11 WO PCT/US2009/056599 patent/WO2010033426A2/en active Application Filing
- 2009-09-11 MY MYPI2011001027A patent/MY155635A/en unknown
- 2009-09-11 CN CN200980145776.XA patent/CN102215837B/zh active Active
- 2009-09-11 JP JP2011527883A patent/JP2012502998A/ja active Pending
- 2009-09-11 CA CA2736774A patent/CA2736774C/en active Active
- 2009-09-11 BR BRPI0919412A patent/BRPI0919412A8/pt not_active Application Discontinuation
- 2009-09-11 RU RU2011115182/10A patent/RU2011115182A/ru not_active Application Discontinuation
-
2011
- 2011-04-18 ZA ZA2011/02909A patent/ZA201102909B/en unknown
-
2014
- 2014-09-11 JP JP2014185260A patent/JP2015038088A/ja active Pending
-
2015
- 2015-03-02 JP JP2015040292A patent/JP6185500B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP6185500B2 (ja) | 2017-08-23 |
EP2344150A2 (en) | 2011-07-20 |
CN102215837A (zh) | 2011-10-12 |
MX2011002984A (es) | 2011-08-08 |
US20110223136A1 (en) | 2011-09-15 |
US9827216B2 (en) | 2017-11-28 |
CA2736774A1 (en) | 2010-03-25 |
BRPI0919412A2 (pt) | 2015-12-15 |
AU2009293476A1 (en) | 2010-03-25 |
JP2015131829A (ja) | 2015-07-23 |
AU2009293476B2 (en) | 2013-01-24 |
EP2687209A1 (en) | 2014-01-22 |
CN102215837B (zh) | 2014-04-30 |
JP2015038088A (ja) | 2015-02-26 |
ZA201102909B (en) | 2014-10-29 |
MY155635A (en) | 2015-11-13 |
CA2736774C (en) | 2017-08-22 |
WO2010033426A2 (en) | 2010-03-25 |
WO2010033426A3 (en) | 2010-11-18 |
RU2011115182A (ru) | 2012-10-27 |
JP2012502998A (ja) | 2012-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0919412A8 (pt) | composição imunonutricional e nutricional,agente intensificador de resposta imunológica e uso do mesmo. | |
HRP20181353T1 (hr) | Tuberkulozni protein rv2386c, njegovi pripravci i upotreba | |
IL252561A0 (en) | Antibodies against Siglac-15 polynucleotides encoding them, preparations containing them and their uses | |
BRPI0919193A2 (pt) | Uso de lipídeo, e, composição nutricional | |
BRPI0923823A2 (pt) | Agente de colaboração. | |
IL211762A0 (en) | Pegylated opiods, compositions comprising the same and uses thereof | |
IL209277A0 (en) | Human anti-il-6/il-6r antibodies, compositions comprising the same and uses thereof | |
IL212836A0 (en) | Azaquinolinone derivatives, compositions comprising the same and uses thereof | |
IL204607A0 (en) | Antibodies against osteoclast - related protein siglec - 15, compositions comprising the same and uses thereof | |
IL216014A0 (en) | Antibodies immunorective with heregulin-her3 complexes, compositions comprising the same and uses thereof | |
EP2153838A4 (en) | ANTI-NOROVIRUS AGENT AND COMPOSITION COMPRISING SAME | |
BRPI0821276A2 (pt) | Produto, e, uso do produto | |
IL212278A0 (en) | Morpholinopurine derivatives, compositions comprising the same and uses thereof | |
EP2354161A4 (en) | ANTI-NR10 ANTIBODIES AND CORRESPONDING USE | |
BRPI0806589A2 (pt) | Catalisador, sua preparação e uso. | |
ZA201008348B (en) | Alcohol alkoxylates, agents comprising the same and use of the alcohol alkoxylates as adjuvants in the agrochemical field. | |
BRPI0920953A2 (pt) | dispositivo de manutenção, e uso do mesmo. | |
BRPI0815922A2 (pt) | Artigo, composição, e, método. | |
BRPI0911252A2 (pt) | método, extrato, e, composição. | |
BRPI0913175A2 (pt) | artigo antibalístico, e, uso do mesmo. | |
IL236601A0 (en) | Antibodies against cytomegalovirus, preparations containing them and their uses | |
IT1397595B1 (it) | Sostanze coloranti e loro utilizzazione in composizioni, in particolare in composizioni cosmetiche. | |
EP2305771A4 (en) | PHOSPHORESCENCE-EMITTING COMPOSITION, AND LIGHT-EMITTING ELEMENT USING THE SAME | |
BRPI0915527A2 (pt) | pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos | |
BRPI0911772A2 (pt) | composto, composição farmacêutica, e, uso do composto. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B25A | Requested transfer of rights approved |
Owner name: INSTITUT CURIE (FR) ; SOCIETE DES PRODUITS NESTLE Owner name: INSTITUT CURIE (FR) ; SOCIETE DES PRODUITS NESTLE S.A. (CH) |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |